Nevada Health Center COVID-19 Survey Summary Report

Latest data from January 14, 2022

Number of Health Center respondents = 6 (75% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 7,738
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 80.32%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 3,759
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 80.73%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 19.07% 18.94%
White, Hispanic/Latino Patients 45.36% 54.64%
Black/African American, Non-Hispanic/Latino Patients 11.79% 12.98%
Black/African American, Hispanic/Latino Patients 0.04% 0.03%
Asian Patients3 10.84% 0.85%
American Indian/Alaska Native Patients3 0.53% 0.61%
Native Hawaiian/Other Pacific Islander Patients3 1.96% 2.50%
Patients with More Than One Race3 5.36% 6.04%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.96% 1.68%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.47% 0.19%
Unreported/Refused to Report Race and Ethnicity 2.61% 1.54%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 667
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 91.00%
COVID-19 Immunization Series Completed 556
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 83.77%
COVID-19 Immunization Series Additional 1,954
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 77.19%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 8.25% 14.57% 20.78%
White, Hispanic/Latino Patients 13.34% 15.47% 15.76%
Black/African American, Non-Hispanic/Latino Patients 11.69% 11.33% 6.45%
Black/African American, Hispanic/Latino Patients 0.75% 0.36% 0.82%
Asian Patients3 7.65% 4.50% 10.90%
American Indian/Alaska Native Patients3 0.45% 1.26% 0.82%
Native Hawaiian/Other Pacific Islander Patients3 1.20% 1.62% 0.97%
Patients with More Than One Race3 27.14% 24.64% 23.90%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 21.14% 16.01% 10.70%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.90% 2.52% 1.33%
Unreported/Refused to Report Race and Ethnicity 7.50% 7.73% 7.57%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 0.00%
1 to 24 Hours 50.00%
More Than 24 Hours 33.33%
N/A 16.67%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 16.67%
Vaccine confidence 16.67%
Vaccine storage capacity 16.67%
Vaccine supply 16.67%
Other 16.67%
None 50.00%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 33.33%
Average Percent of Health Center Visits Conducted Virtually 25.83%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 50.00%
Number of Mobile Van Sites 1
Number of Pop-up Clinics 2
Number of School-Based Vaccination Sites 3
Number of Family Vaccination Clinics 1

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 50.00%
None 50.00%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 50.00%
Patient awareness/education 33.33%
Staffing capacity 33.33%
Therapy administration/onsite logistics 33.33%
Other 0.00%
None 50.00%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 2
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 1,590

Test Kit Distribution Methods4

Metrics Value
Provide to Existing Health Center Patients 50.00%
Provide to General Public Who Came to the Health Center 100.00%
Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 50.00%
Provide at Other Community Events 50.00%
Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) 50.00%
Other 0.00%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 0
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 -

Oral Antiviral Medication Distribution by Race and Ethnicity5

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients -
White, Hispanic/Latino Patients -
Black/African American, Non-Hispanic/Latino Patients -
Black/African American, Hispanic/Latino Patients -
Asian Patients3 -
American Indian/Alaska Native Patients3 -
Native Hawaiian/Other Pacific Islander Patients3 -
Patients with More Than One Race3 -
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) -
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) -
Unreported/Refused to Report Race and Ethnicity -

Oral Antiviral Medication Distribution by Special/Vulnerable Population5

Metrics Value
Migratory/Agricultural Workers -
Patients Experiencing Homelessness -
Patients Who Are Residents of Public Housing -
Patients with Limited English Proficiency -
Children Under 18 Years of Age -

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.

Date Last Reviewed:  January 2022